HPV Vaccine Peptide Constructs with Ligand-Inducible Gene Switch Systems

The USPTO published patent application US20260098063A1 disclosing engineered HPV vaccine constructs and ligand-inducible engineered gene switch systems for modulating expression of heterologous genes such as cytokines in host cells. The application covers novel molecular vaccine constructs with CPC classifications including C07K 14/005, A61K 39/12, and A61K 39/292. Inventors include Douglas E. Brough, Cheryl G. Bolinger, Ramya Yarlagadda, Vinodhbabu Kurella, Prabakaran Ponraj, Simon Metenou, and Kuan-fu Ding.

Affected parties including pharmaceutical companies, vaccine developers, and biotechnology firms should monitor this publication for competitive intelligence purposes. Patent applications do not create compliance obligations but represent the beginning of the examination process that could eventually lead to granted patent rights covering HPV vaccine compositions and gene expression modulation systems.